This ingredient has a low sensitization risk and testing shows it does not classify as a skin irritant or sensitizer
Combining both compounds creates unnecessary cardiovascular strain
Clinical trial data from the STEP program showed that semaglutide 2.4mg weekly produced average weight loss of 14.9% of body weight over 68 weeks, compared to tirzepatide at 15mg which achieved approximately 22.5% in the SURMOUNT trials
It is a bit of a ride from Toronto to the clinic, but super worth it:) Thanks Aileen!Ethan Carter2024-02-11I visited here for a combined mesotherapy, exosome facial, and micro needling treatment to address my acne scars
Liraglutide, a glucagon-like peptide-1 analog, induce autophagy and senescence in HepG2 cells
Acknowledgements We would like to thank Brenda Guthrie Yoshinaga (Skybay Scientific Editing) for editing of the manuscript